Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Genomics Luminary and former Illumina Executive Bob Kain Joins Single Technologies as an Advisor

Stockholm, Sweden, 23 April 2024 – Renowned genomics pioneer, Bob Kain, has joined Single Technologies as an advisor to support the commercialization of their 3-D DNA sequencing system.Kain is perhaps most famous for his work at Illumina from 1999 to 2014. During this time, he not only helped the company grow from a 30-employee start-up into a commercial giant with more than $1.5bn in annual revenues, but also helped invent and commercialize the first modern, high throughput genome sequencer. Kain’s work has helped bring the cost of sequencing a full human genome from several millions of

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.’s holding in Metso

Metso Corporation’s stock exchange release on April 23, 2024, at 10:00 a.m. EESTMetso Corporation has received a notification, pursuant to Chapter 9, Section 5 and 6 of the Finnish Securities Markets Act, about a change in the shareholding of BlackRock, Inc. On April 19, 2024, BlackRock's holding in Metso’s shares fell below the 5 percent threshold and amounted to 41,425,323 shares or 4.99 percent of total shares and votes. BlackRock's holding through financial instruments in Metso amounted to 1,131,822 shares, which corresponds to 0.13 percent of the total amount of Metso’s shares. On

#24-36 Trading halt in Imsys AB

NGM has decided to halt the trading in the shares and warrants TO7 of Imsys AB effective immediately. Trading will be halted until further notice in accordance with Chapter 11, Section 12 of the Securities Market Act. The Financial Supervisory Authority has been notified about the trade halt and has decided that it will remain until further notice in accordance with Chapter 22, Section 1 of the Securities Market Act. Information regarding the affected instruments:  Listing name: Imsys Exchange symbol: IMSYS ISIN-code: SE0021309689 CFI-code: ESVUFR FISN-code: IMSYS/SH

University medical centers in Germany choose Sectra’s radiology solution to streamline workflows and shorten lead times for patients

Linköping, Sweden – April 23, 2024 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany—Universitätsklinikum Tübingen and Universitätsmedizin Göttingen. By implementing Sectra’s radiology solution, the hospitals aim to improve and streamline radiology workflows with Sectra’s tools for enhanced reporting efficiency, in turn speeding up diagnostics.“When choosing a vendor, we wanted one that could provide

Prevas acquire Enmac and establish a strong strategic platform in Finland

Prevas has signed an agreement to acquire approximately 92 percent of the shares in the Finnish company NMAC Group Oy, the parent company of Enmac Oy ("Enmac"). Enmac has a strong position in the Finnish market within growth areas such as energy, industrial automation, and process industry, with approximately 200 employees and a turnover of EUR 23 million in 2023. Through the acquisition, which is Prevas’ first in Finland, a Nordic group is established, with operations across Sweden, Norway, Denmark and Finland. The acquisition will enable future market synergies and is in line with Prevas'

Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) announces its first day of trading on Nasdaq First North under its new company name

Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) will start trading on Nasdaq First North Stockholm under the ticker PERP B today.Following the extraordinary general meeting’s resolution to adopt a new articles of association, the Swedish Companies Registration Office (Swe: Bolagsverket) has approved the company’s submission, after which Nasdaq has approved the application to change the name of the company. The first day of trading will take place today, April 23, 2024, under the ticker PERP B. The new name reflects the company’s ambition to be a long-term owner of profitable

United Bankers Plc: Notification of Manager’s Transactions – Noramaa, Inka

United Bankers Plc STOCK EXCHANGE RELEASE 23 April 2024 at 09:30 EEST   United Bankers Plc: Notification of Manager’s Transactions – Noramaa, Inka ____________________________________________ Person subject to the notification requirement Name: Inka Noramaa Position: Other senior manager Issuer: United Bankers Oyj LEI: 743700J2WO3J6XGFPG77 Notification type: INITIAL NOTIFICATION Reference number: 59179/5/4   ____________________________________________ Transaction date: 2024-04-22 Outside a trading venue Instrument type: SHARE ISIN:

Stora Enso Oyj: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act (19 April 2024)

STORA ENSO OYJ STOCK EXCHANGE RELEASE 23 April 2024 at 9:30 EESTStora Enso Oyj has received a notification pursuant to chapter 9, section 5 of the Securities Market Act from BlackRock, Inc on 22 April 2024. On 19 April 2024, BlackRock's total holding, including holding through financial instruments, in Stora Enso’s shares increased above the 5 percent threshold. +----------------+--------------+-----------------------------+---------------+|  |% of shares |% of shares and voting rights|Total of both || |and voting |through financial

MindArk is Redefining AI Application Through Innovation in Leadership

Entropia Universe Unveils Plans to Develop the First-Ever AI President to Lead Its Epic Virtual World.With limitless application potential through the gaming industry and beyond, Entropia Universe is taking a monumental leap forward by announcing the development of the world's first AI President to govern its metaverse. MindArk strives to usher in a new era where cutting-edge artificial intelligence meets virtual world management in game, providing the player with unique experiences through the real money economy system.Entropia Universe is a gaming platform where every skill you learn

Notice to Annual General Meeting in Cinis Fertilizer AB

The shareholders of Cinis Fertilizer AB, reg. no 559154-0322, are hereby summoned to the annual general meeting to be held on May 23, 2024, at 4.00 p.m. CEST at Advokatfirman Schjødt at Hamngatan 27, Stockholm, Sweden. The entrance to the meeting and registration will open at 3.30 p.m. CEST.The board of directors has decided, pursuant to the company’s articles of association, that shareholders shall also have the right to exercise their voting rights by postal voting. Shareholders may therefore choose to exercise their voting rights at the general meeting by attending in person, through a

Repurchases of shares by Attendo AB during week 16, 202

Between 15 April 2024 and 19 April 2024 Attendo AB (LEI code 549300KEJDL2FNITUW65) (“Attendo”) has repurchased in total 303,768 own shares (ISIN: SE0007666110) as part of the repurchase program initiated by the BoardThe repurchases form part of the repurchase program of a maximum of 16,138,659 own shares for a total maximum amount of SEK 110,000,000 that Attendo announced on 8 February 2024. The repurchase program, which runs between 9 February 2024 and 24 April 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation

Carras Aquataurus Becomes World’s First Vessel to Earn ABS Biofuel-1 Notation

(ATHENS) Carras (Hellas) S.A. is taking the next step in its sustainability journey by receiving the ABS Biofuel-1 notation for its Aquataurus ultramax bulk carrier, the first vessel in the world to qualify. The notation is assigned to vessels that use a biofuel blend of up to and including 30 percent biofuel in compliance with IMO and ABS requirements. Biofuels are liquid hydrocarbon fuels with similar composition and properties to fuel oil, but they are produced from renewable sources such as crops, agricultural and forestry waste, animal waste, or vegetable and animal

Interim Report Byggmax Group 1 January - 31 March, 2024

More stores, lower costs and significantly reduced net debt ”The first quarter of 2024 developed as expected. Byggmax’s focus on strengthening the customer offering, efficient operations, and optimizing inventory levels gave effect. In addition to lower costs, net debt is significantly reduced versus the corresponding quarter last year. With more stores, lower costs, and an optimized inventory, Byggmax is ready for a new season”. Karl Sandlund, President and CEOThe first quarter of 2024 · Net sales amounted to SEK 866 M (952), representing a decrease of 9.0 percent. · Exchange

The journey to the important harvest of 2024 has begun with a cold spring

This year's harvest is more important than it has been for a long time, not least because of the poor harvest last year, which has led to a need to replenish Swedish food stocks. The challenges of agriculture in 2023 have been described as a perfect storm – too dry at the beginning of the summer, and then too wet. The consequence was a smaller harvest and poorer quality which, together with, among other things, high energy costs, high fertilizer prices and increased interest costs, created major challenges for many farmers.  "Last year's poor harvest was tough for many farmers, who were

Interim report January-March 2024

· Income amounted to SEK 940 million (1,172) · Operating surplus amounted to SEK 578 million (789) · Net financial income amounted to SEK –320 million (–387) · Profit from property management amounted to SEK 215 million (356) · Changes in value of properties amounted to SEK –484 million (–1,505) · Changes in value of derivatives amounted to SEK 135 million (–231) · Net letting amount to SEK 49 million · Profit/loss for the period amounted to SEK –158 million (–911), corresponding to SEK –0.28 (–0.95) per ordinary share of class A and B · The value of investment

Embla Medical hf: Interim Report Q1 2024

Announcement no. 10/2024 Interim report Q1 2024 23 April 2024 Sveinn Sölvason, President and CEO, comments: “Sales growth was strong in the first quarter or 10% and organic growth was 7%, driven by volume growth in Prosthetics & Neuro Orthotics and Patient Care. Growth was driven by a strong performance in EMEA, but the year started off slowly in Americas and APAC. Financial performance of FIOR & GENTZ, which we acquired in January, was strong in the first quarter post-acquisition and work has begun to leverage our global sales infrastructure to harvest commercial synergies.

S&P Global Ratings assigns BB+ issuer credit rating to Finnair Plc. Further, a 200M€ revolving credit facility for the company

Finnair Plc           Investor News          23 April 2024 at 9:00 p.m. EEST On 23 April 2024, S&P Global Ratings has assigned a long-term issuer credit rating of BB+ to Finnair Plc, with a stable outlook. It is the first credit rating for Finnair. A public rating enables deeper funding sources from the debt capital markets and increases the execution certainty of financing transactions. In addition, Finnair has on 23 April 2024 signed a binding secured revolving credit facility of 200 million euros for general corporate purposes. The transaction is coordinated by Nordea Bank Abp and

Coor and ICA extend their collaboration

Coor has extended its IFM agreement with Swedish retailer ICA with five years. The contract starts on 1 November 2024 with a total value during the contract period of more than SEK 1 Bn, including estimated contract volumes.ICA Gruppen AB is a leading retail company with a focus on food and health in Sweden and the Baltics. The IFM contract entails that Coor will continue to deliver property, workplace including cleaning, and security services to 20 of ICA’s warehouse and logistics facilities and offices around Sweden, in a partnership agreement. “We’re delighted to receive ICA’s renewed

STOREBRAND ASA: Reminder - Invitation to Result Presentation Q1 2024

In connection with the release of the results for Q1 2024, Storebrand invites to the following events: Wednesday 24 April 2024 07.30 CET Release of stock exchange notification. Press release, quarterly report and analyst presentation will be available on www.storebrand.com/ir . 10.00 CET Live streamed investor and analyst conference in English. A webcast will be available for everyone to view on www.storebrand.com/ir, and will be available on demand afterwards. Analysts who would like to ask

Viking Line: Somewhat weaker first quarter demand

Viking Line Abp                       BUSINESS REVIEW                        23.04.2024, 9.00 AMSomewhat weaker first quarter demand   JANUARY-MARCH 2024 (compared to January–March 2023)  · Sales amounted to EUR 93.2 M (EUR 93.9 M). · Other operating revenue was EUR 0.4 M (EUR 8.8 M). · Operating income totalled EUR -10.4 M (EUR -0.9 M). · Net financial items were EUR -3.8 M (EUR -3.7 M). · Income before taxes totalled EUR -14.2 M (EUR -4.6 M, including the EUR 8.6 M capital gain from the sale of Rosella). · Income after taxes was EUR -14.3 M (EUR -3.9 M). ·

Today is the first day of the subscription period in SciBase rights issue

Today, 23 April 2024, the subscription period in SciBase Holding AB (publ) ("SciBase" or the "Company") rights issue of units of up to approximately SEK 15 million commences (the "Rights Issue"). The Rights Issue was resolved by the Board of Directors in SciBase on 5 April 2024, pursuant to the authorisation granted by the Annual General Meeting held on 17 May 2023.THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR

Launch update for MOB-015

STOCKHOLM, April 23[rd], 2024, Moberg Pharma AB (OMX:MOB) reports strong interest from pharmacists, physicians and end customers in the launch of MOB-015 under the brand Terclara[®] in Sweden. A majority of Swedish pharmacies now have the product available on the shelf.Interest in the product exceeds the pharmacy chains' forecasts, and chains are increasing their orders due to that Terclara[®] has occasionally sold out at several of the pharmacy chains. However, there is a well-stocked wholesale warehouse.  Patients are also verifying the great need for new treatment options for nail

There are no items matching the current filter
There are no more items matching the current filter
Back to top